Step Pharma is a biotechnology company discovering and developing proprietary small molecule therapeutics for the treatment of auto-immune diseases. Step’s lead program is selective modulators against specific immune cell populations which are the main drivers of auto-immune diseases.

Our Company

Step Pharma Establishes Scientific Advisory Board

Paris, France, 25th February 2018 - Step Pharma, a company focused on the development new oral treatments of a range of autoimmune diseases today announced the establishment of a Scientific Advisory Board to help guide the development of the company's…

Step Pharma Completes €14.5 million Series A Financing with Additional New Investor

Paris, France, 21 November 2017 – Step Pharma today announced the closing of a Series A financing totalling €14.5 million. Pontifax joined existing investors led by Kurma Partners, and including Bpifrance (Fonds Biothérapies Innovantes et Maladies Rares),…

Contact us for more information